SCHEMBL1625599

SCHEMBL1625599

CCC(C)c1ccc(OC(=O)Oc2ccccc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
TSHR P16473 2/20 0.59
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
FFAR1 O14842 1/20 0.48
FAAH O00519 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
ESR1 P03372 1/20 0.46
HIF1A Q16665 1/20 0.46
SLC7A5 Q01650 1/20 0.46
CASP1 P29466 1/20 0.45
LTB4R Q15722 1/20 0.45
LTB4R2 Q9NPC1 1/20 0.45
MTNR1A P48039 3/20 0.44
MTNR1B P49286 3/20 0.44
ACACB O00763 1/20 0.43
ACACA Q13085 1/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15294616 0.86 ALDH1A1 (0.58) ALDH1A1TSHRNPC1RAB9AFAAH
SCHEMBL13144362 0.86 ALDH1A1 (0.55) ALDH1A1TSHRNPC1RAB9AFFAR1
SCHEMBL14483862 0.85 ALDH1A1 (0.51) ALDH1A1TSHRNPC1RAB9AMEN1
SCHEMBL6119949 0.85 FFAR1 (0.52) ALDH1A1TSHRFFAR1FAAHMEN1
SCHEMBL6721979 0.84 ALDH1A1 (0.56) ALDH1A1TSHRNPC1RAB9AFFAR1
SCHEMBL28222075 0.84 ESR1 (0.46) ALDH1A1TSHRNPC1RAB9AESR1
SCHEMBL1509141 0.84 ESR1 (0.46) ALDH1A1TSHRNPC1RAB9AESR1
SCHEMBL1789851 0.84 ALDH1A1 (0.53) ALDH1A1TSHRNPC1RAB9AMEN1
SCHEMBL18959912 0.83 ALDH1A1 (0.59) ALDH1A1TSHRNPC1RAB9AMEN1
SCHEMBL10127207 0.83 KMT2A (0.57) ALDH1A1TSHRNPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8507711-B2 Flame-retardant compound, flame-retardant particle, resin composition and resin formed body FUJI XEROX CO., LTD. (JP) 2013-08-13 US disclosed
US-8507711-B2 Flame-retardant compound, flame-retardant particle, resin composition and resin formed body FUJI XEROX CO., LTD. (JP) 2013-08-13 US disclosed
US-8455571-B2 Flame-retardant particle, resin composition and resin formed body FUJI XEROX CO., LTD. (JP) 2013-06-04 US disclosed
US-20120088871-A1 FLAME-RETARDANT COMPOUND, FLAME-RETARDANT PARTICLE, RESIN COMPOSITION AND RESIN FORMED BODY FUJI XEROX CO., LTD. (JP) 2012-04-12 US disclosed
US-20120088871-A1 FLAME-RETARDANT COMPOUND, FLAME-RETARDANT PARTICLE, RESIN COMPOSITION AND RESIN FORMED BODY FUJI XEROX CO., LTD. (JP) 2012-04-12 US disclosed
US-20090087659-A1 FLAME-RETARDANT COMPOUND, FLAME-RETARDANT PARTICLE, RESIN COMPOSITION AND RESIN FORMED BODY FUJI XEROX CO., LTD. (JP) 2009-04-02 US disclosed
US-20090087659-A1 FLAME-RETARDANT COMPOUND, FLAME-RETARDANT PARTICLE, RESIN COMPOSITION AND RESIN FORMED BODY FUJI XEROX CO., LTD. (JP) 2009-04-02 US disclosed
US-20090088495-A1 FLAME-RETARDANT PARTICLE, RESIN COMPOSITION AND RESIN FORMED BODY FUJI XEROX CO., LTD. (JP) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090087659-A1 FLAME-RETARDANT COMPOUND, FLAME-RETARDANT PARTICLE, RESIN COMPOSITION AND RESIN FORMED BODY GAR1, RER1, AFF1 ALDH1A1 537/4885TSHR 930/4885NPC1 2846/4885
US-20120088871-A1 FLAME-RETARDANT COMPOUND, FLAME-RETARDANT PARTICLE, RESIN COMPOSITION AND RESIN FORMED BODY GAR1, RER1, RFT1 ALDH1A1 993/4885TSHR 980/4885NPC1 3274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.